Bristol-Myers Squibb, Pfizer to Highlight Commitment to Reducing the Risk of Stroke Caused by Non-Valvular Atrial Fibrillation and Treating Deep Vein Thrombosis/Pulmonary Embolism  at ESC Congress 2017